| CAS ID: | 83-98-7 |
| Molecular Formula: | C18H23NO |
| Molecular Weight: | 269.4 g/mol |
| Monoisotopic Mass: | 269.178 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | Invagesic | ORPHENADRINE CITRATE | ORPHENADINE CITRATE | Norgesic | ORPHENADRINE (CHLORIDE) | DISIPAL | ORPHENADRINE HYDROCHLORIDE | ORPHENADRINE (CITRATE) | Orphengesic | ORPHENADRINE | BIORPHEN | Disipal | Norflex | NORFLEX |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02423395 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Unknown |
| First Received | April 22, 2015 | Last Verified | May 30, 2017 |
| Sponsor | Sherief Abd-Elsalam | ||